SenzaGen AB
SSE:SENZA.ST
6.7 (SEK) • At close February 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 49.87 | 41.77 | 15.422 | 7.958 | 2.724 | 1.997 | 1.153 | 0.498 | 1.748 | 1.624 |
| Cost of Revenue
| 14.938 | 14.434 | 5.969 | 5.006 | -0.776 | -7.258 | -9.156 | 1.673 | 2.355 | 1.351 |
| Gross Profit
| 34.932 | 27.336 | 9.453 | 2.952 | 3.5 | 9.255 | 10.309 | -1.175 | -0.607 | 0.273 |
| Gross Profit Ratio
| 0.7 | 0.654 | 0.613 | 0.371 | 1.285 | 4.634 | 8.941 | -2.359 | -0.347 | 0.168 |
| Reseach & Development Expenses
| 3.747 | 8.985 | 3.874 | 2.626 | 10.835 | 5.794 | 5.866 | 0 | 0 | 0 |
| General & Administrative Expenses
| 19.138 | 17.418 | 15.55 | 8.357 | 18.535 | 17.787 | 18.849 | 5.656 | 4.401 | 0 |
| Selling & Marketing Expenses
| 26.787 | 21.609 | 21.234 | 20.841 | 16.627 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 45.925 | 39.027 | 36.784 | 29.198 | 18.535 | 17.787 | 18.849 | 5.656 | 4.401 | 1.582 |
| Other Expenses
| 0 | -0.486 | 0.328 | 0.852 | 22.892 | 12.199 | 8.066 | 4.505 | 0.137 | 0 |
| Operating Expenses
| 49.672 | 47.526 | 40.986 | 30.05 | 41.427 | 29.986 | 26.915 | 10.161 | 4.276 | 0.063 |
| Operating Income
| -14.74 | -20.19 | -31.533 | -27.098 | -37.927 | -20.731 | -16.606 | -11.336 | -4.883 | 0.434 |
| Operating Income Ratio
| -0.296 | -0.483 | -2.045 | -3.405 | -13.923 | -10.381 | -14.402 | -22.763 | -2.793 | 0.267 |
| Total Other Income Expenses Net
| -7.236 | -4.772 | 0.168 | -0.07 | 0.184 | 0.124 | -0.018 | -0.053 | 0.043 | -0.098 |
| Income Before Tax
| -21.976 | -24.962 | -31.365 | -27.168 | -37.743 | -20.607 | -16.624 | -11.389 | -4.84 | 0.336 |
| Income Before Tax Ratio
| -0.441 | -0.598 | -2.034 | -3.414 | -13.856 | -10.319 | -14.418 | -22.869 | -2.769 | 0.207 |
| Income Tax Expense
| 0.121 | -0.05 | -0.019 | 0.147 | 12.494 | -4.517 | -3.548 | -2.477 | -1.983 | 0.074 |
| Net Income
| -22.097 | -24.912 | -31.346 | -27.315 | -50.237 | -16.09 | -12.994 | -8.942 | -2.857 | 0.262 |
| Net Income Ratio
| -0.443 | -0.596 | -2.033 | -3.432 | -18.442 | -8.057 | -11.27 | -17.956 | -1.634 | 0.161 |
| EPS
| -0.91 | -1.03 | -1.3 | -1.28 | -3.11 | -1.04 | -1.61 | -0.83 | -0.26 | 0.052 |
| EPS Diluted
| -0.91 | -1.03 | -1.3 | -1.28 | -3.11 | -1.04 | -1.61 | -0.81 | -0.26 | 0.052 |
| EBITDA
| -6.554 | -10.575 | -27.078 | -23.195 | -34.738 | -19.28 | -15.994 | -11.058 | -4.596 | 0.459 |
| EBITDA Ratio
| -0.131 | -0.253 | -1.756 | -2.915 | -12.753 | -9.654 | -13.872 | -22.205 | -2.629 | 0.283 |